BACKGROUND: Postpartum hemorrhage is a leading cause of maternal mortality.
Antifibrinolytic therapy has the potential to influence outcomes in postpartum hemorrhage …

November 2020• Volume 131• Number 5 www. anesthesia-analgesia. org 1371 also lag
behind other coagulation tests. Plus, tests for these markers of fibrinolysis are more difficult …

Background Haemorrhage is a common cause of morbidity and mortality in the obstetric
population. The aim of this study was to compare the use of thromboelastography and …

BACKGROUND: Rapid assessment of hemostasis during postpartum hemorrhage (PPH) is
essential to allow characterization of coagulopathy, to estimate bleeding severity, and to …

Objectives To establish whether reagent‐supported thrombelastometry with the rotation
thrombelastometry system (ROTEM®) point‐of‐care device correlated with fibrinogen level …

Introduction Coagulopathy may be the result of hyperfibrinolysis and could exacerbate
bleeding following childbirth. Timely recognition of hyperfibrinolysis during the earliest …

BACKGROUND: Hemostatic disorders are common in obstetric complications.
Thromboelastography (TEG®) simultaneously measures coagulation and fibrinolysis within …

Anticipating obstetric coagulopathy is important when obstetric anaesthetists are involved in
the clinical management of women with postpartum haemorrhage. Although the incidence of …

Thrombelastography® is a monitor of coagulation and fibrinolytic status, with point-of-care
applications in managing haemorrhaging patients. Advocates have suggested a possible …

Thrombelastography (TEG), which evaluates the elastic properties of whole blood and
provides a global assessment of hemostatic function, is useful in managing peripartum …